SEC Form 4 · accession 0001596771-15-000022
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary W Kadlec
Officer — President · Director
Period of report
Mar 3, 2015
Accepted (ET)
Mar 3, 2015 · 5:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $4.28 | Mar 3, 2015 | A | 96,688 | A | — | Sep 1, 2022 | Common Stock | 96,688 | 193,376 | D |
Explanation of responses
- F1On September 1, 2012, Mr. Kadlec was granted an option to purchase 386,750 shares of common stock. The option vests according to certain financial performance criteria of the Issuer, and on March 3, 2015, target revenue amounts were met, allowing for the vesting of 25% of the option as to 96,688 shares.